Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells
DOI: 10.1186/s12987-020-00197-1
Authors: Misaki Yamashita; Hiromasa Aoki; Tadahiro Hashita; Takahiro Iwao; Tamihide Matsunaga
Step 1: iPSC/ESC maintainance
day 0 ~ 3
culture “adherent” human PSC in “StemSure hPSC medium” for “3” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| FGF | 3.5e-5 | g/l |
Ideally, “PSC” should be obtained at the end of culture.
Step 2: endothelial 1
day 3 ~ 4
culture “adherent” human PSC in “DMEM/F12” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| KSR | 20 | % |
| Glutamine | 0.002 | mol/l |
| NEAA | 1 | % |
| 2-mercaptoethanol | 1.0e-4 | mol/l |
Step 3: endothelial 2
day 4 ~ 8
culture “adherent” human PSC in “Human Endothelial-SFM” for “4” days. For ECM, use “fibronectin/collagen IV” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “4” days.
| concentration | unit | |
|---|---|---|
| PDS | 1 | % |
| FGF | 2.0e-5 | g/l |
| retinoic acid | 1.0e-5 | mol/l |
| A83-01 | 1.0e-6 | mol/l |
| SB431542 | 1.0e-6 | mol/l |
| RepSox | 1.0e-6 | mol/l |
Ideally, “EC” should be obtained at the end of culture.